The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
20 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
must have experienced bladder pain, urinary urgency and frequency for at least 6 months prior to entry into the study
Pain VAS >4
PUF score >13
ICQ score >12
4) cystoscopic record within 2years
Patients who are pregnancy or, childbearing age without no contraception
Patient with microscopic hematuria, if not excluded that no evidence of neoplastic tumor examination
patients with urine culture showing evidence of urinary tract infection 1month prior to the study
Accompanied medical problem below
Tuberculosis in urinary system
Bladder cancer, urethral cancer, Prostate cancer
Patients had prior surgery (bladder augmentation, cystectomy)
Patients with neurologic disorder
Patients with indwelling catheter or intermittent self-catheterization